menu
    • menu

    Company profile for Alcami

    NEW Drugs in Dev: 1
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    A lot of people in the CDMO industry claim they offer end-to-end service. What gets in the way is a lack of program management – support that the industry is asking for. Alcami is the first to actually make this happen – a unified solution for customers across various technologies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AlcamiUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2320 Scientific Park DriveWilmington, North Carolina
    Telephone
    Telephone
    (800) 575-4224
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.alcaminow.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/alcami-corporation
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/alcaminow

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alcami Expands Biologic Capabilities With RTP Facility
    Alcami Expands Biologic Capabilities With RTP Facility

    19 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alcami-acquires-rtp-facility-to-further-expand-biologic-capabilities-302663871.html

    PR NEWSWIRE
    19 Jan 2026
    Share Share
    Alcami Expands Drug Product Manufacturing For Rising Demand
    Alcami Expands Drug Product Manufacturing For Rising Demand

    16 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alcami-expands-drug-product-manufacturing-capacity-to-meet-growing-demand-302643577.html

    PR NEWSWIRE
    16 Dec 2025
    Share Share
    Alcami Expands Lab Services In Durham For Biologics Demand
    Alcami Expands Lab Services In Durham For Biologics Demand

    21 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alcami-to-expand-laboratory-services-footprint-at-durham-nc-facility-to-meet-growing-demand-in-biologics-302590195.html

    PR NEWSWIRE
    21 Oct 2025
    Share Share
    Alcami Appoints Key Leaders for Drug Product Manufacturing
    Alcami Appoints Key Leaders for Drug Product Manufacturing

    11 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alcami-announces-key-leadership-appointments-in-drug-product-manufacturing-302501483.html

    PR NEWSWIRE
    11 Jul 2025
    Share Share
    Alcami Appoints Tori E. Arens as President, Drug Product
    Alcami Appoints Tori E. Arens as President, Drug Product

    12 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alcami-appoints-tori-e-arens-as-president-drug-product-302374325.html

    PR NEWSWIRE
    12 Feb 2025
    Share Share
    Alcami Names Tori E. Arens as President of Drug Product
    Alcami Names Tori E. Arens as President of Drug Product

    12 Feb 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/alcami-names-tori-e-arens-as-president-of-drug-product/

    CONTRACTPHARMA
    12 Feb 2025
    Share Share

    USDMF

    read-more
    read-more

    01

    Anastrozole

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow

    02

    Bromfenac Sodium (fp-098)

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow

    03

    Dexmedetomidine Hydrochloride Usp (f...

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Dexmedetomidine Hydrochloride Usp (f...

    U.S.A
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Alcami

    GDUFA

    DMF Review : Complete

    Rev. Date : 2013-01-09

    Pay. Date : 2012-12-24

    DMF Number : 22681

    Submission : 2009-03-31

    Status : Active

    Type : II

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Dexrazoxane (fp-048)

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow

    05

    Fp-059 (fomepizole) Drug Substance

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow

    06

    Isradipine (fp-043)

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow

    07

    Letrozole, Usp

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow

    08

    Midodrine Hydrochloride Usp

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow

    09

    Pilocarpine (fp-039)

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow

    10

    Fp-062

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Fp-062

    U.S.A
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Alcami

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 19736

    Submission : 2006-11-07

    Status : Inactive

    Type : II

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    KDMF

    read-more
    read-more

    01

    Anagrelide hydrochloride

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Anagrelide hydrochloride

    U.S.A
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Alcami

    Registrant Name : Takeda Pharmaceutical Company Korea Co., Ltd.

    Registration Date : 2009-06-17

    Registration Number : 22-4-ND

    Manufacturer Name : Sterling Wisconsin, LLC@[Micro...

    Manufacturer Address : W130 N10497 Washington Drive, Germantown, WI 53022, USA@20 Pacific Drive, Quakertown,...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    02

    Carfilzomib

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Carfilzomib

    U.S.A
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Alcami

    Registrant Name : Amgen Korea Ltd.

    Registration Date : 2016-08-18

    Registration Number : Su36-1-ND

    Manufacturer Name : Sterling Wisconsin, LLC

    Manufacturer Address : W130 N10497 Washington Drive Germantown, WI 53022-4448, USA

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Drugs in Development

    read-more
    read-more
    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products

    Details:

    PharmaTher is evolving to become a leader in ketamine-based solutions for mental health, neurological and pain disorders, and partnering with Alcami as our exclusive manufacturer for the clinical and commercial supply of ketamine.


    Lead Product(s): Ketamine Hydrochloride

    Therapeutic Area: Neurology Brand Name: Ketarx

    Study Phase: Phase I/ Phase IIProduct Type: Controlled Substance

    Recipient: PharmaTher

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement October 19, 2021

    blank

    01

    Alcami

    U.S.A
    arrow
    International Sweetener Colloquium
    Not Confirmed

    Alcami

    U.S.A
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Ketamine Hydrochloride

    Therapeutic Area : Neurology

    Highest Development Status : Phase I/ Phase II

    Recipient : PharmaTher

    Deal Size : Undisclosed

    Deal Type : Agreement

    DEALS_DEV arrow-down

    PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products

    Details : PharmaTher is evolving to become a leader in ketamine-based solutions for mental health, neurological and pain disorders, and partnering with Alcami as our exclusive manufacturer for the clinical and commercial supply of ketamine.

    Product Name : Ketarx

    Product Type : Controlled Substance

    Upfront Cash : Undisclosed

    October 19, 2021

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Alcami Providing Commercial Manufacturing for Trevena’s Recently FDA Approved OLINVYK

    Details:

    Alcami is providing commercial manufacturing services for Trevena's newly approved OLINVYK. OLINVYK (oliceridine) injection is an opioid approved in adults for the management of acute pain severe enough to require an intravenous opioid analgesic.


    Lead Product(s): Oliceridine

    Therapeutic Area: Neurology Brand Name: Olinvyk

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Sponsor: Trevena

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement August 26, 2020

    blank

    02

    Alcami

    U.S.A
    arrow
    International Sweetener Colloquium
    Not Confirmed

    Alcami

    U.S.A
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Oliceridine

    Therapeutic Area : Neurology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Trevena

    Deal Size : Undisclosed

    Deal Type : Agreement

    DEALS_DEV arrow-down

    Alcami Providing Commercial Manufacturing for Trevena’s Recently FDA Approved OLINVYK

    Details : Alcami is providing commercial manufacturing services for Trevena's newly approved OLINVYK. OLINVYK (oliceridine) injection is an opioid approved in adults for the management of acute pain severe enough to require an intravenous opioid analgesic.

    Product Name : Olinvyk

    Product Type : Miscellaneous

    Upfront Cash : Undisclosed

    August 26, 2020

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Alcami and get a quotation

    Alcami is a supplier offers 12 products (APIs, Excipients or Intermediates).

    Find a price of Dexmedetomidine Hydrochloride bulk with DMF offered by Alcami

    Find a price of Dexrazoxane bulk with DMF offered by Alcami

    Find a price of Fomepizole bulk with DMF offered by Alcami

    Find a price of Midodrine bulk with DMF offered by Alcami

    Find a price of Vinyl Chloride bulk with DMF offered by Alcami

    Find a price of Anastrozole bulk offered by Alcami

    Find a price of Bromfenac Sodium bulk offered by Alcami

    Find a price of Ferrocene bulk offered by Alcami

    Find a price of Letrozole bulk offered by Alcami

    Find a price of FP-062 bulk offered by Alcami

    Find a price of Anagrelide Hydrochloride bulk offered by Alcami

    Find a price of Carfilzomib bulk offered by Alcami

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search